Influenza News and Research

Latest Influenza News and Research

Daiichi Sankyo launches Inavir inhalation powder in Japan

Hovione has been advised by Daiichi Sankyo Company Ltd that Inavir(R) has been launched in Japan. Inavir(R) is an inhalation powder which is delivered by the TwinCaps(R) inhaler to treat influenza. TwinCaps(R) was specifically designed by Hovione for this indication and is licensed to Daiichi Sankyo and to Biota Holdings Ltd.

22 Oct 2010

Baxter third quarter net income increases 12% to $595 million

Baxter International Inc. today announced its financial results for the third quarter of 2010, and provided its fourth quarter and updated full-year 2010 financial outlook.

From Baxter International Inc. 21 Oct 2010

BioCryst to present intravenous peramivir data for influenza treatment at IDSA meeting

BioCryst Pharmaceuticals, Inc. announced the presentation of data related to intravenous (i.v.) peramivir for the treatment of influenza at the 48th Annual Infectious Diseases Society of America (IDSA) meeting being held in Vancouver, Canada.

21 Oct 2010

Intercell and Romark announce IC41-nitazoxanide combination clinical trials for HCV

Intercell AG and Romark Laboratories L.C. today announced plans to commence clinical trials of Intercell's investigational therapeutic Hepatitis C virus (HCV) vaccine, IC41, in combination with Romark's antiviral drug, nitazoxanide, during the first half of 2011.

21 Oct 2010

Federal court to allow Calif. case on Medicare underpayments to move forward; LA county gets new health department head

A recent court decision gave a group of California counties another chance to challenge what they contend are severe Medicare underpayments that jeopardize access to care across the country.

19 Oct 2010

Egg allergy is no reason to avoid 2010-2011 flu vaccination

Having an egg allergy is not a reason to avoid getting the 2010-2011 flu vaccination.

19 Oct 2010

Higher Medicaid reimbursement rates could increase childhood vaccinations

Reuters: A new study in the journal Pediatrics suggests that raising Medicaid reimbursement rates could help more children from low-income families receive flu vaccinations. "Although the vaccine itself is provided free of charge to children covered by Medicaid, doctors are only reimbursed for about half the cost of administering it," and are losing money in the process, say researchers.

18 Oct 2010

NanoViricides' President delivers speech at ASNM Second Annual Conference

NanoViricides, Inc. announced today that the Company President was invited to and presented a talk at the Second Annual Conference of the American Society for NanoMedicine (ASNM).

18 Oct 2010

Study finds correlation between flu vaccination and Medicaid reimbursement rates

Increasing the amount that physicians are reimbursed by Medicaid for administering influenza shots may raise vaccination rates among poor children. That is the conclusion of a study published online today in the journal Pediatrics.

18 Oct 2010

Silver studded bacteria could help treat common cold and flu

Finally scientists may have found a potential cure for common cold. They have found “silver bullets” in yogurt that could destroy viruses and provide a cure for the flu and common cold.

18 Oct 2010

OTIS urges pregnant women to get vaccinated against influenza

The Organization of Teratology Information Specialists (OTIS), a non-profit organization based at the University of California, San Diego with affiliates across North America, urges pregnant women to receive the influenza vaccine as soon as possible. The recommendation comes shortly after the American College of Obstetricians and Gynecologists Committee on Obstetric Practice issued new guidelines regarding the influenza vaccine during pregnancy.

15 Oct 2010

Oseltamivir reduces mortality in influenza A/H5N1 patients

A study published in the Journal of Infectious Diseases indicates that treatment with oseltamivir significantly reduces mortality in patients with influenza A/H5N1, or 'bird flu', even when given late in the course of illness.

15 Oct 2010

LifeBridge Health reveals two ways to prevent seasonal flu

You're having that dreaded feeling. Your muscles are aching, you've got a a fever and sore throat . Get ready: It is flu season again! The flu is a respiratory virus that's contagious. In addition to the symptoms above, a, cough and headache, as well as diarrhea may indicate the virus is present.

15 Oct 2010

NanoViricides files financial year end annual report with SEC

NanoViricides, Inc. reports that it has filed its financial year end annual report (Form 10K) with the Securities and Exchange Commission (SEC) yesterday in a timely manner.

14 Oct 2010

Top citations for scientific paper on Inovio's SynCon DNA vaccines and ID DNA delivery technology

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that a scientific paper demonstrating strong and protective immune responses from candidate SynCon™ DNA vaccines in preclinical studies using Inovio's intradermal (ID) DNA delivery technology was one of the top cited scientific articles in the past three years in the journal Vaccine.

14 Oct 2010

Scientists identify environmental conditions that could enable H5N1 bird flu virus to survive

On the eve of the 2010-11 influenza flu season, scientists and engineers have identified the environmental conditions and surfaces that could enable a highly pathogenic (H5N1) bird flu virus to survive for prolonged periods of time at least two weeks and up to two months. Among them: The virus appears to thrive at cooler temperatures and low humidity.

14 Oct 2010

Medicago and PATH partner on development of broad coverage influenza vaccine

Medicago Inc., a biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced that it has been awarded $946,000 in funding by U.S.-based PATH pursuant to a research collaboration agreement. Medicago and PATH will work together on a broad coverage influenza vaccine based on Medicago's proprietary plant-based Virus-Like Particle (VLP) technologies for the developing world.

13 Oct 2010

$1.5 million DOD award allows U-M scientists to pursue new application for nanoemulsion technology

The U.S. Department of Defense has awarded $1.5 million over three years to the Michigan Nanotechnology Institute for Medicine and Biological Sciences and to Ann Arbor-based NanoBio Corporation to develop and test nanoemulsions with potential to fight a wide range of wound infections, including drug-resistant forms.

13 Oct 2010

CSL to distribute Cerus' INTERCEPT Blood System in Australia, New Zealand

Cerus Corporation announced today that it has entered into an agreement with CSL Limited, Biotherapies division to distribute Cerus' INTERCEPT Blood System for platelets in Australia and New Zealand. The INTERCEPT Blood System is designed to provide increased protection from a broad range of transfusion-transmitted pathogens, including bacteria and emerging pathogens such as the dengue and chikungunya viruses.

13 Oct 2010

QIAGEN, Abbott enter agreement to strengthen testing menus for automated in-vitro diagnostic applications

QIAGEN and Abbott today announced that they have entered into an agreement that significantly strengthens both companies' testing menus for automated in-vitro diagnostic applications in the United States and Canada. Financial terms were not disclosed.

From QIAGEN Manchester Limited 13 Oct 2010

Influenza News and Research

Latest Influenza News and Research

Daiichi Sankyo launches Inavir inhalation powder in Japan

Baxter third quarter net income increases 12% to $595 million

BioCryst to present intravenous peramivir data for influenza treatment at IDSA meeting

Intercell and Romark announce IC41-nitazoxanide combination clinical trials for HCV

Federal court to allow Calif. case on Medicare underpayments to move forward; LA county gets new health department head

Egg allergy is no reason to avoid 2010-2011 flu vaccination

Higher Medicaid reimbursement rates could increase childhood vaccinations

NanoViricides' President delivers speech at ASNM Second Annual Conference

Study finds correlation between flu vaccination and Medicaid reimbursement rates

Silver studded bacteria could help treat common cold and flu

OTIS urges pregnant women to get vaccinated against influenza

Oseltamivir reduces mortality in influenza A/H5N1 patients

LifeBridge Health reveals two ways to prevent seasonal flu

NanoViricides files financial year end annual report with SEC

Top citations for scientific paper on Inovio's SynCon DNA vaccines and ID DNA delivery technology

Scientists identify environmental conditions that could enable H5N1 bird flu virus to survive

Medicago and PATH partner on development of broad coverage influenza vaccine

$1.5 million DOD award allows U-M scientists to pursue new application for nanoemulsion technology

CSL to distribute Cerus' INTERCEPT Blood System in Australia, New Zealand

QIAGEN, Abbott enter agreement to strengthen testing menus for automated in-vitro diagnostic applications

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Influenza News and Research

Latest Influenza News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in